ArticleJHEP reports : innovation in hepatology2026

Pathological response ≥90% predicts survival in HCC treated with neoadjuvant loco-regional therapies: A retrospective cohort study.

Li-Ying Ou-Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.